Edition:
United States

Repligen Corp (RGEN.OQ)

RGEN.OQ on NASDAQ Stock Exchange Global Select Market

28.60USD
4:00pm EDT
Change (% chg)

$0.75 (+2.69%)
Prev Close
$27.85
Open
$27.86
Day's High
$29.01
Day's Low
$27.78
Volume
105,455
Avg. Vol
--
52-wk High
--
52-wk Low
--

Latest Key Developments (Source: Significant Developments)

Repligen announces pricing of $100 mln of 2.125 pct convertible senior notes due 2021
Thursday, 19 May 2016 08:41am EDT 

Repligen Corp :Repligen announces pricing of $100 million of 2.125 pct convertible senior notes due 2021.  Full Article

Repligen Corp files for mixed shelf offering - SEC filing
Wednesday, 18 May 2016 06:05pm EDT 

Repligen Corp : Repligen Corp files for mixed shelf offering, size not disclosed Source - http://bit.ly/1WExHpA Further company coverage: [RGEN.O] (Bengaluru Newsroom: +1 646 223 8780).  Full Article

Repligen to offer $100 mln of convertible senior notes
Wednesday, 18 May 2016 04:20pm EDT 

Repligen Corp :Repligen announces proposed public offering of $100 million of convertible senior notes due 2021.  Full Article

Repligen Corp announces extension of long term supply agreement for Protein A
Wednesday, 24 Feb 2016 04:59pm EST 

Repligen Corp:Announces extension of long term supply agreement for protein a.Says has extended through 2019 a key long-term supply agreement with GE healthcare for the manufacture of protein a ligands.  Full Article

Repligen Corp raises FY 2015 revenue guidance
Thursday, 6 Aug 2015 07:30am EDT 

Repligen Corp:Sees FY 2015 revenue to be in the range of $78-$82 million, an increase from previous guidance of $75-$78 million.Says revenue projection for FY 2015 is comprised exclusively of bioprocessing product sales.  Full Article

Repligen Corp raises FY 2015 guidance
Thursday, 7 May 2015 07:30am EDT 

Repligen Corp:Expects FY 2015 revenue range of $75-$78 million, an increase from previous guidance of $72-$75 million.Expects FY 2015 total income from operations to be $14-$16 million, an increase from previous guidance of $12-$14 million.Expects FY 2015 net income to be $10-$12 million, an increase from previous guidance of $8-$10 million.FY 2015 net income of $10, EBIT of $13 million and revenue of $73 million - Thomson Reuters I/B/E/S.  Full Article

Repligen Corp gives FY 2015 mixed guidance
Friday, 13 Mar 2015 07:00am EDT 

Repligen Corp:Expects FY 2015 total revenue of $72-$75 million, comprised exclusively of product sales, and reflecting 19pct-24pct sales growth.Expects FY 2015 total income from operations to be $12-$14 million.Expects FY 2015 net income to be $8-$10 million, reflecting estimated taxes of about $4 million.FY 2015 revenue of $71 million, EBIT of $15 million and net income of $12 million - Thomson Reuters I/B/E/S.  Full Article

Repligen Corp names tony hunt as next chief executive officer
Wednesday, 21 Jan 2015 07:00am EST 

Repligen Corp:Appointed Tony J. Hunt to be the company's next chief executive officer.Hunt, Repligen's Chief Operating Officer, will succeed Walter C. Herlihy, Ph.D., who will retire as President and CEO effective May 21, the date of the company's annual meeting of stockholders.  Full Article

Repligen Corp raises low end of prior FY 2014 revenue outlook to a range in line with analysts' estimates; reaffirms FY 2014 earnings outlook
Thursday, 6 Nov 2014 07:32am EST 

Repligen Corp:Says total revenue for FY 2014 is expected to be $60-$62 million, adjustment to previous guidance of $59-$62 million.Says consistent with previous guidance total income from operations for FY 2014 is expected to be $11-$13 million.Says consistent with previous guidance total net income projection for FY 2014 is $8-$10 million.FY 2014 revenue of $61 million, net income of $9 million and EBIT of $12 million - Thomson Reuters I/B/E/S.  Full Article

Repligen Corp raises FY 2014 outlook
Monday, 11 Aug 2014 07:01am EDT 

Repligen Corp:Expects FY 2014 revenue to be $59-$62 mln, an increase from previous guidance of $58-$61 mln.Expects FY 2014 total income from operations to be $11-$13 mln, increased from previous guidance of $10-$12 mln.FY 2014 revenue of $59 mln, EBIT of $11 mln - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Repligen announces pricing of $100 mln of 2.125 pct convertible senior notes due 2021

* Repligen announces pricing of $100 million of 2.125 pct convertible senior notes due 2021 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)